Literature DB >> 11544452

Proliferation and release of IL-5 and IFN-gamma by peripheral blood mononuclear cells from cat-allergic asthmatics and rhinitics, non-cat-allergic asthmatics, and normal controls to peptides derived from Fel d 1 chain 1.

B M Haselden1, E Syrigou, M Jones, D Huston, K Ichikawa, M D Chapman, A B Kay, M Larché.   

Abstract

BACKGROUND: In general, T cells from normal, nonatopic individuals respond to aeroallergens with synthesis and release of IFN-gamma. In contrast, release of T(H)2-type cytokines by activated lymphocytes is a feature of allergic rhinitis and atopic asthma.
OBJECTIVE: The purpose of this study was to determine differences in T-cell recognition of epitopes within allergenic sequences, in terms of proliferation and cytokine production, in subjects with atopic asthma compared with subjects with allergic rhinitis and normal controls.
METHODS: Proliferative responses and IL-5/IFN-gamma release patterns from PBMCs from cat-allergic asthmatic, cat-allergic rhinitic, and non-cat-allergic asthmatic subjects and nonatopic normal controls were determined in primary cultures. Cells were challenged with 7 overlapping peptides spanning chain 1 of the major cat allergen, Fel d 1.
RESULTS: The 4 groups did not differ with respect to the ability to mount proliferative responses to Fel d 1 peptides. In all groups, the IFN-gamma responses were predominantly to the amino terminus peptides. Cat-allergic and non-cat-allergic asthmatic subjects (and not cat-allergic rhinitic subjects and normal controls) made IL-5 responses to most of the Fel d 1 peptides, the result being a mixed (T(H)0) cytokine response at the N-terminus and a restricted (T(H)2) response at the C-terminus.
CONCLUSION: Proliferative and IL-5/IFN-gamma responses of T cells from asthmatic and atopic rhinitic subjects and normal controls to allergen peptides can be dissociated. Furthermore, differing cytokine responses to peptides derived from a single antigen suggest that certain domains of the molecule might preferentially induce IL-5 rather than IFN-gamma and as a result could be more important in disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11544452     DOI: 10.1067/mai.2001.117461

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  9 in total

1.  Use of multiple peptides containing T cell epitopes is a feasible approach for peptide-based immunotherapy in Can f 1 allergy.

Authors:  Anu K Immonen; Antti H Taivainen; Ale T O Närvänen; Tuure T Kinnunen; Soili A Saarelainen; Marja A Rytkönen-Nissinen; Tuomas I Virtanen
Journal:  Immunology       Date:  2007-01       Impact factor: 7.397

2.  The mold conundrum in chronic hyperplastic sinusitis.

Authors:  Fenna A Ebbens; Christos Georgalas; Wytske J Fokkens
Journal:  Curr Allergy Asthma Rep       Date:  2009-03       Impact factor: 4.806

3.  Molecular determinants of T cell epitope recognition to the common Timothy grass allergen.

Authors:  Carla Oseroff; John Sidney; Maya F Kotturi; Ravi Kolla; Rafeul Alam; David H Broide; Stephen I Wasserman; Daniela Weiskopf; Denise M McKinney; Jo L Chung; Arnd Petersen; Howard Grey; Bjoern Peters; Alessandro Sette
Journal:  J Immunol       Date:  2010-06-16       Impact factor: 5.422

4.  Allergen-specific in vitro cytokine production in adult patients with eosinophilic esophagitis.

Authors:  Kiyoshi Yamazaki; Joseph A Murray; Amindra S Arora; Jeffery A Alexander; Thomas C Smyrk; Joseph H Butterfield; Hirohito Kita
Journal:  Dig Dis Sci       Date:  2006-09-29       Impact factor: 3.199

5.  Direct ex vivo analysis of allergen-specific CD4+ T cells.

Authors:  William W Kwok; Michelle Roti; Jonathan H Delong; Venus Tan; Erik Wambre; Eddie A James; David Robinson
Journal:  J Allergy Clin Immunol       Date:  2010-06       Impact factor: 10.793

6.  Tracking antigen-specific T-cells during clinical tolerance induction in humans.

Authors:  Aamir Aslam; Hsien Chan; David A Warrell; Siraj Misbah; Graham S Ogg
Journal:  PLoS One       Date:  2010-06-09       Impact factor: 3.240

Review 7.  The mold conundrum in chronic rhinosinusitis: where do we stand today?

Authors:  Fenna A Ebbens; Wytske J Fokkens
Journal:  Curr Allergy Asthma Rep       Date:  2008-04       Impact factor: 4.806

Review 8.  Allergen-Specific CD4(+) T Cells in Human Asthma.

Authors:  Morris F Ling; Andrew D Luster
Journal:  Ann Am Thorac Soc       Date:  2016-03

Review 9.  New directions in immunotherapy.

Authors:  Linda Cox; Enrico Compalati; Thomas Kundig; Mark Larche
Journal:  Curr Allergy Asthma Rep       Date:  2013-04       Impact factor: 4.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.